116 related articles for article (PubMed ID: 34020239)
1. Insight on a new indolinone derivative as an orally bioavailable lead compound against renal cell carcinoma.
Fouad MA; Zaki MY; Lotfy RA; Mahmoud WR
Bioorg Chem; 2021 Jul; 112():104985. PubMed ID: 34020239
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking of new sulfonamide-based indolinone derivatives as multitargeted kinase inhibitors against leukemia.
El-Hussieny M; El-Sayed NF; Fouad MA; Ewies EF
Bioorg Chem; 2021 Dec; 117():105421. PubMed ID: 34666258
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
[TBL] [Abstract][Full Text] [Related]
4. Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides.
Eldehna WM; El Kerdawy AM; Al-Ansary GH; Al-Rashood ST; Ali MM; Mahmoud AE
Eur J Med Chem; 2019 Feb; 163():37-53. PubMed ID: 30503942
[TBL] [Abstract][Full Text] [Related]
5. S-(4-Methoxyphenyl)-4-methoxybenzenesulfonothioate as a Promising Lead Compound for the Development of a Renal Carcinoma Agent.
Nantes CI; Pereira ID; Bai R; Hamel E; Burnett JC; de Oliveira RJ; de F C Matos M; Beatriz A; Yonekawa MKA; Perdomo RT; de Lima DP; Bogo D; Dos A Dos Santos E
ChemMedChem; 2020 Mar; 15(5):449-458. PubMed ID: 31834975
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Evaluation of New Bis-Indolinone Derivatives Endowed with Cytotoxic Activity.
Morigi R; Catanzaro E; Locatelli A; Calcabrini C; Pellicioni V; Leoni A; Fimognari C
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684858
[TBL] [Abstract][Full Text] [Related]
7. Novel Azine Linked Hybrids of 2-Indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies.
Qayed WS; Hassan MA; El-Sayed WM; Rogério A Silva J; Aboul-Fadl T
Bioorg Chem; 2022 Sep; 126():105884. PubMed ID: 35623140
[TBL] [Abstract][Full Text] [Related]
8. Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
Hsieh MH; Tsai JP; Yang SF; Chiou HL; Lin CL; Hsieh YH; Chang HR
Cells; 2019 Aug; 8(9):. PubMed ID: 31438640
[TBL] [Abstract][Full Text] [Related]
9. The indolylcoumarin COUFIN exhibits potent activity against renal carcinoma cells without affecting hematopoietic system.
Champelovier P; Barbier P; Daras E; Douillard S; Toussaint B; Persoon V; Curri V; Peyrot V; Combes S
Anticancer Agents Med Chem; 2014; 14(6):862-71. PubMed ID: 24568163
[TBL] [Abstract][Full Text] [Related]
10. Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy.
Zheng Y; Ma Y; Cao H; Yan L; Gu Y; Ren X; Jiao X; Wan S; Shao F
Bioorg Chem; 2021 Mar; 108():104561. PubMed ID: 33349457
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors.
Donthiboina K; Anchi P; Sri Ramya PV; Karri S; Srinivasulu G; Godugu C; Shankaraiah N; Kamal A
Bioorg Chem; 2019 May; 86():210-223. PubMed ID: 30716619
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Al-Hussain SA; Farghaly TA; Zaki MEA; Abdulwahab HG; Al-Qurashi NT; Muhammad ZA
Bioorg Chem; 2020 Dec; 105():104330. PubMed ID: 33038552
[TBL] [Abstract][Full Text] [Related]
13. Fe
Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of some novel thiobenzimidazole derivatives as anti-renal cancer agents through inhibition of c-MET kinase.
Ibrahim HS; Albakri ME; Mahmoud WR; Allam HA; Reda AM; Abdel-Aziz HA
Bioorg Chem; 2019 Apr; 85():337-348. PubMed ID: 30658233
[TBL] [Abstract][Full Text] [Related]
15. Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.
Huang M; Huang Y; Guo J; Yu L; Chang Y; Wang X; Luo J; Huang Y; Tu Z; Lu X; Xu Y; Zhang Z; Zhang Z; Ding K
Eur J Med Chem; 2021 Feb; 211():113023. PubMed ID: 33248853
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a stable and orally bioavailable englerin analogue.
Fash DM; Peer CJ; Li Z; Talisman IJ; Hayavi S; Sulzmaier FJ; Ramos JW; Sourbier C; Neckers L; Figg WD; Beutler JA; Chain WJ
Bioorg Med Chem Lett; 2016 Jun; 26(11):2641-4. PubMed ID: 27107948
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
Selka A; Doiron JA; Lyons P; Dastous S; Chiasson A; Cormier M; Turcotte S; Surette ME; Touaibia M
Eur J Med Chem; 2019 Oct; 179():347-357. PubMed ID: 31260889
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of imidazo-thiadiazole linked indolinone conjugates and evaluated their microtubule network disrupting and apoptosis inducing ability.
Narasimha Rao MP; Nagaraju B; Kovvuri J; Polepalli S; Alavala S; Vishnuvardhan MVPS; Swapna P; Nimbarte VD; Lakshmi JK; Jain N; Kamal A
Bioorg Chem; 2018 Feb; 76():420-436. PubMed ID: 29275261
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
